Venus Concept (VERO) 10-Q 10 Nov 22 2022 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2022	Nov. 08, 2022
Document Information [Line Items]
Entity Central Index Key	0001409269
Entity Registrant Name	Venus Concept Inc.
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-38238
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	06-1681204
Entity Address, Address Line One	235 Yorkland Blvd., Suite 900
Entity Address, City or Town	Toronto
Entity Address, State or Province	ON
Entity Address, Postal Zip Code	M2J 4Y8
City Area Code	877
Local Phone Number	848-8430
Title of 12(b) Security	Common Stock, $0.0001 par value per share
Trading Symbol	VERO
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		67,584,573

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
CURRENT ASSETS:
Cash and cash equivalents	$ 6,777	$ 30,876
Accounts receivable, net of allowance of $13,102 and $11,997 as of September 30, 2022, and December 31, 2021, respectively	40,876	46,918
Inventories	24,241	20,543
Prepaid expenses	1,912	2,737
Advances to suppliers	3,605	2,162
Other current assets	3,351	3,758
Total current assets	80,762	106,994
LONG-TERM ASSETS:
Long-term trade receivables	23,253	27,710
Deferred tax assets	912	284
Severance pay funds	724	817
Property and equipment, net	2,180	2,669
Intangible assets	12,795	15,393
Total long-term assets	39,864	46,873
TOTAL ASSETS	120,626	153,867
CURRENT LIABILITIES:
Trade payables	6,093	4,913
Accrued expenses and other current liabilities	17,335	19,512
Income taxes payable	827	294
Unearned interest income	2,575	2,678
Warranty accrual	1,147	1,245
Deferred revenues	1,535	2,030
Current portion of government assistance loans	0	543
Total current liabilities	29,512	31,215
LONG-TERM LIABILITIES:
Long-term debt	77,616	77,325
Income tax payable	592	563
Accrued severance pay	845	911
Deferred tax liabilities	54	46
Unearned interest income	1,355	1,355
Warranty accrual	426	508
Other long-term liabilities	213	348
Total long-term liabilities	81,101	81,056
TOTAL LIABILITIES	110,613	112,271
Commitments and Contingencies (Note 8)
STOCKHOLDERS’ EQUITY:
Common Stock, $0.0001 par value: 300,000,000 shares authorized as of September 30, 2022 and December 31, 2021; 65,584,573 and 63,982,580 issued and outstanding as of September 30, 2022, and December 31, 2021, respectively	27	27
Additional paid-in capital	223,506	221,321
Accumulated deficit	(214,188)	(180,405)
TOTAL STOCKHOLDERS’ EQUITY	9,345	40,943
Non-controlling interests	668	653
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance	10,013	41,596
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 120,626	$ 153,867

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Accounts receivable, allowance, current	$ 13,102	$ 11,997
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	300,000,000	300,000,000
Common stock, shares issued (in shares)	65,584,573	63,982,580
Common stock, shares outstanding (in shares)	65,584,573	63,982,580

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenue
Revenues	$ 21,539	$ 24,563	$ 75,211	$ 72,988
Cost of goods sold
Cost of goods and services sold	8,166	7,257	25,029	21,731
Gross profit	13,373	17,306	50,182	51,257
Operating expenses:
Sales and marketing	8,094	8,775	27,484	26,743
General and administrative	14,128	11,990	41,471	31,983
Research and development	2,576	1,930	7,214	6,005
Gain on forgiveness of government assistance loans	0	0	0	(2,775)
Total operating expenses	24,798	22,695	76,169	61,956
Loss from operations	(11,425)	(5,389)	(25,987)	(10,699)
Other expenses:
Foreign exchange loss	2,014	1,645	4,389	2,489
Finance expenses	1,219	1,000	3,176	4,046
Loss on disposal of subsidiaries	0	188	0	188
Loss before income taxes	(14,658)	(8,222)	(33,552)	(17,422)
Income tax (benefit) expense	(162)	616	92	609
Net loss	(14,496)	(8,838)	(33,644)	(18,031)
Net loss attributable to stockholders of the Company	(14,605)	(9,798)	(33,783)	(18,680)
Net income attributable to non-controlling interest	$ 109	$ 960	$ 139	$ 649
Net loss per share:
Basic (in dollars per share)	$ (0.22)	$ (0.18)	$ (0.52)	$ (0.35)
Diluted (in dollars per share)	$ (0.22)	$ (0.18)	$ (0.52)	$ (0.35)
Weighted-average number of shares used in per share calculation:
Basic (in shares)	65,255	54,145	64,462	53,994
Diluted (in shares)	65,255	54,145	64,462	53,994
Leases [Member]
Revenue
Revenues	$ 7,193	$ 12,634	$ 29,490	$ 33,958
Cost of goods sold
Cost of goods and services sold	2,608	2,938	8,069	7,444
Products and Services [Member]
Revenue
Revenues	14,346	11,929	45,721	39,030
Cost of goods sold
Cost of goods and services sold	$ 5,558	$ 4,319	$ 16,960	$ 14,287

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net loss	$ (14,496)	$ (8,838)	$ (33,644)	$ (18,031)
Loss attributable to stockholders of the Company	(14,605)	(9,798)	(33,783)	(18,680)
Income attributable to non-controlling interest	109	960	139	649
Comprehensive loss	$ (14,496)	$ (8,838)	$ (33,644)	$ (18,031)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Preferred Stock [Member] Series A Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Noncontrolling Interest [Member]	Total
Balance (in shares) at Dec. 31, 2020	0	53,551,126
Balance at Dec. 31, 2020	$ 0	$ 26	$ 201,598	$ (157,392)	$ (471)	$ 43,761
Options exercised (in shares)	0	157,304
Options exercised	$ 0		212	0	0	212
Net income (loss) — the Company	0	0	0	(9,259)	0	(9,259)
Income attributable to non-controlling interest	0	0	0	0	(176)	(176)
Stock-based compensation	$ 0	$ 0	508	0	0	508
December 2020 Public Offering warrants exercise (in shares)	0	361,200
December 2020 Public Offering warrants exercise	$ 0	$ 0	903	0	0	903
Balance (in shares) at Mar. 31, 2021	0	54,069,630
Balance at Mar. 31, 2021	$ 0	$ 26	203,221	(166,651)	(647)	35,949
Balance (in shares) at Dec. 31, 2020	0	53,551,126
Balance at Dec. 31, 2020	$ 0	$ 26	201,598	(157,392)	(471)	43,761
Net income (loss) — the Company						(18,680)
Income attributable to non-controlling interest						649
Balance (in shares) at Sep. 30, 2021	0	54,157,969
Balance at Sep. 30, 2021	$ 0	$ 26	204,094	(176,072)	723	28,771
Balance (in shares) at Dec. 31, 2020	0	53,551,126
Balance at Dec. 31, 2020	$ 0	$ 26	201,598	(157,392)	(471)	43,761
Balance (in shares) at Dec. 31, 2021	3,790,755	63,982,580
Balance at Dec. 31, 2021	$ 0	$ 27	221,321	(180,405)	653	41,596
Balance (in shares) at Mar. 31, 2021	0	54,069,630
Balance at Mar. 31, 2021	$ 0	$ 26	203,221	(166,651)	(647)	35,949
Options exercised (in shares)	0	72,192
Options exercised	$ 0		98			98
Net income (loss) — the Company	0	0	0	377	0	377
Income attributable to non-controlling interest	0	0	0	0	(135)	(135)
Stock-based compensation	$ 0	$ 0	558	0	0	558
Balance (in shares) at Jun. 30, 2021	0	54,141,822
Balance at Jun. 30, 2021	$ 0	$ 26	203,877	(166,274)	(782)	36,847
Options exercised (in shares)	0	16,147
Options exercised	$ 0		22			22
Net income (loss) — the Company	0	0	0	(9,798)	0	(9,798)
Income attributable to non-controlling interest	0	0	0	0	960	960
Stock-based compensation	0	0	536	0	0	536
Acquisition of non-controlling interest	0	0	(341)	0	341	0
Disposal of subsidiary	$ 0	$ 0	0	0	204	204
Balance (in shares) at Sep. 30, 2021	0	54,157,969
Balance at Sep. 30, 2021	$ 0	$ 26	204,094	(176,072)	723	28,771
Balance (in shares) at Dec. 31, 2021	3,790,755	63,982,580
Balance at Dec. 31, 2021	$ 0	$ 27	221,321	(180,405)	653	41,596
Options exercised (in shares)	0	16,464
Options exercised	$ 0	$ 0	23	0	0	23
Net income (loss) — the Company	0	0	0	(8,619)	0	(8,619)
Income attributable to non-controlling interest	0	0	0	0	(17)	(17)
Stock-based compensation	$ 0	$ 0	443	0	0	443
Balance (in shares) at Mar. 31, 2022	3,790,755	63,999,044
Balance at Mar. 31, 2022	$ 0	$ 27	221,787	(189,024)	636	33,426
Balance (in shares) at Dec. 31, 2021	3,790,755	63,982,580
Balance at Dec. 31, 2021	$ 0	$ 27	221,321	(180,405)	653	$ 41,596
Options exercised (in shares)						16,464
Net income (loss) — the Company						$ (33,783)
Income attributable to non-controlling interest						139
Balance (in shares) at Sep. 30, 2022	3,790,755	65,584,573
Balance at Sep. 30, 2022	$ 0	$ 27	223,506	(214,188)	668	10,013
Balance (in shares) at Mar. 31, 2022	3,790,755	63,999,044
Balance at Mar. 31, 2022	$ 0	$ 27	221,787	(189,024)	636	33,426
Net income (loss) — the Company	0	0	0	(10,559)	0	(10,559)
Income attributable to non-controlling interest	0	0	0	0	47	47
Stock-based compensation	$ 0	$ 0	558	0	0	558
Equity issuance (in shares)	0	400,000
Equity issuance	$ 0	$ 0	48	0	0	48
Dividends from subsidiaries	$ 0	$ 0	0	0	(124)	(124)
Balance (in shares) at Jun. 30, 2022	3,790,755	64,399,044
Balance at Jun. 30, 2022	$ 0	$ 27	222,393	(199,583)	559	23,396
Net income (loss) — the Company	0	0	0	(14,605)	0	(14,605)
Income attributable to non-controlling interest	0	0	0	0	109	109
Stock-based compensation	$ 0	$ 0	551	0	0	551
Equity issuance (in shares)	0	1,185,529
Equity issuance	$ 0	$ 0	562	0	0	562
Dividends from subsidiaries	$ 0	$ 0	0	0	0	0
Balance (in shares) at Sep. 30, 2022	3,790,755	65,584,573
Balance at Sep. 30, 2022	$ 0	$ 27	$ 223,506	$ (214,188)	$ 668	$ 10,013

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (14,496)		$ (8,838)	$ (33,644)	$ (18,031)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization				3,293	3,756
Stock-based compensation				1,552	1,602
Provision (recovery) for bad debt	2,391	$ 1,004		5,912	(628)	$ (263)
Provision for inventory obsolescence				1,753	1,107
Finance expenses and accretion				291	981
Deferred tax recovery				(620)	(666)
Loss on disposal of subsidiary				0	188
Gain on forgiveness of government assistance loans	0		0	0	(2,775)
Loss on disposal of property and equipment				82	0
Changes in operating assets and liabilities:
Accounts receivable short and long-term				4,493	3,468
Inventories				(5,451)	(4,373)
Prepaid expenses				825	(112)
Advances to suppliers				(1,443)	(142)
Other current assets				407	909
Other long-term assets				327	(102)
Trade payables				1,180	(1,573)
Accrued expenses and other current liabilities				(2,237)	(3,135)
Severance pay funds				93	(58)
Unearned interest income				(103)	127
Other long-term liabilities				(283)	87
Net cash used in operating activities				(23,573)	(19,370)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment				(297)	(194)
Cash received from sale of subsidiary, net of cash relinquished				0	(40)
Net cash used in investing activities				(297)	(234)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock, net of costs				415	0
Exercises of 2020 December Public Offering Warrants				0	903
Payment of earn-out liability				0	(147)
Repayment of government assistance loans				(543)	0
Proceeds from exercise of options				23	332
Dividends from subsidiaries paid to non-controlling interest				(124)	0
Net cash (used in) provided by financing activities				(229)	1,088
NET DECREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH				(24,099)	(18,516)
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH — Beginning of period		$ 30,876		30,876	34,380	34,380
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH — End of period	$ 6,777		$ 15,864	6,777	15,864	$ 30,876
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for income taxes				152	120
Cash paid for interest				2,885	2,852
FINANCING INFORMATION:
Common stock issuance costs				$ 438	$ 0

Note 1 - Nature of Operations

Note 1 - Nature of Operations	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Nature of Operations [Text Block]	1. Venus Concept Inc. is a global medical technology company that develops, commercializes, and sells minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The Company’s systems have been designed on cost-effective, proprietary and flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family and general practitioners and aesthetic medical spas. The Company was incorporated in the state of Delaware on November 22, 2002. Going Concern The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the foreseeable future, and, as such, the unaudited condensed consolidated financial statements do not The Company has had recurring net operating losses and negative cash flows from operations. As of September 30, 2022 December 31, 2021 a September 30, 2022 December 31, 2021 12 September 30, 2022 nine 19 19 In order to continue its operations, the Company must achieve profitable operations and/or obtain additional equity or debt financing. Until the Company achieves profitability, management plans to fund its operations and capital expenditures with cash on hand, borrowings, and issuance of capital stock. On June 16, 2020, may two nine September 30, 2022, July 1, 2022. July 12, 2022, “2022 14 December 2021, 2021 14 February 2021, December 2020 December 2020 Given the economic uncertainty in U.S. and international markets, the Company cannot anticipate the extent to which the current economic turmoil and financial market conditions will continue to adversely impact the Company’s business and the Company may no may not Operational Review of Subsidiaries During the three nine September 30, 2022, not three nine September 30, 2022 three nine September 30, 2022. not not 205 20 45.

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Significant Accounting Policies [Text Block]	2. Basis of Presentation The accompanying unaudited condensed consolidated financial statements of Venus Concept Inc. have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and with the instructions to Form 10 10 X. not 10 December 31, 2021 March 28, 2022. nine September 30, 2022 not may December 31, 2022. 8 10 In the Form 10 March 31, 2021, May 17, 2021, 10 June 30, 2021, August 17, 2021, 10 September 30, 2021, November 12, 2021 10 December 31, 2021, March 28, 2022, 16 Reclassification Adjustment Three Months Ended Year Ended March 31, 2021 June 30, 2021 September 30, 2021 December 31, 2021 December 31, 2021 United States $ (362 ) $ (615 ) $ (703 ) $ (440 ) $ (2,120 ) International 362 615 703 440 2,120 Total revenue $ — $ — $ — $ — $ — The preparation of these unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ materially from those estimates. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company as of September 30, 2022 not Amounts reported in thousands within this report are computed based on the amounts in dollars. As a result, the sum of the components reported in thousands may not may not Accounting Policies The accounting policies the Company follows are set forth in the Company’s audited consolidated financial statements for fiscal year 2021 8 10 no JOBS Act Accounting Election The Company is an emerging growth company, within the meaning of the 1933 no may not Recently Adopted Accounting Standards In November 2021, No. 2021 10, 832 December 31, 2021. 12 In May 2021, 2021 04, 260 470 50 718 815 40 1 2 December 15, 2021, not In December 2019, 2019 12 740 first 2022, not Recently Issued Accounting Standards Not In October 2021, No. 2021 08, 805 606, December 15, 2022, In August 2020, No. 2020 06 2020 06” 470 20 815 40 2020 06 2020 06 January 1, 2024, No. 2020 06 In April 2020, 842 840: 19 19. 19 In March 2020, 2020 04 848 2021, March 12, 2020 December 31, 2022. may no December 31, 2022. January 2021, may 848. not In February 2020, 2020 02 326 842 326 842. 326, 326 January 1, 2023,

Note 3 - Net Loss Per Share

Note 3 - Net Loss Per Share	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Earnings Per Share [Text Block]	3. Net Loss Per Share Basic net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding during the period, without consideration for common stock equivalents. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common stock equivalents outstanding for the period determined using the treasury-stock method. For purposes of this calculation, common stock warrants and stock options are considered to be common stock equivalents and are only included in the calculation of diluted net loss per share when their effect is dilutive. The following table sets forth the computation of basic and diluted net loss per share and the weighted average number of shares used in computing basic and diluted net loss per share (in thousands, except per share data): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Numerator: Net loss $ (14,496 ) $ (8,838 ) $ (33,644 ) $ (18,031 ) Net loss allocated to stockholders of the Company $ (14,605 ) $ (9,798 ) $ (33,783 ) $ (18,680 ) Denominator: Weighted-average shares of common stock outstanding used in computing net loss per share, basic 65,255 54,145 64,462 53,994 Weighted-average shares of common stock outstanding used in computing net loss per share, diluted 65,255 54,145 64,462 53,994 Net loss per share: Basic $ (0.22 ) $ (0.18 ) $ (0.52 ) $ (0.35 ) Diluted $ (0.22 ) $ (0.18 ) $ (0.52 ) $ (0.35 ) The following potentially dilutive securities were excluded from the computation of the diluted net loss per share for the periods presented because their effect would have been antidilutive: September 30, 2022 September 30, 2021 Options to purchase common stock and restricted stock units ("RSUs") 7,483,514 5,695,900 Preferred stock 3,790,755 - Shares reserved for convertible notes 8,213,880 8,213,880 Warrants for common stock 15,928,867 15,928,867 Total potential dilutive shares 35,417,016 29,838,647

Note 4 - Fair Value Measurement

Note 4 - Fair Value Measurements	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Fair Value Disclosures [Text Block]	4. Financial assets and financial liabilities are initially recognized at fair value when the Company becomes a party to the contractual provisions of the financial instrument. Subsequently, all financial instruments are measured at amortized cost using the effective interest method, except for GIC which is at fair value. The financial instruments of the Company consist of cash and cash equivalents, restricted cash, accounts receivable, long-term receivables, lines of credit, trade payables, government assistance loans, accrued expenses and other current liabilities, other long-term liabilities and long-term debt. In view of their nature, the fair value of these financial instruments approximates their carrying amounts. The Company measures the fair value of its financial assets and financial liabilities using the fair value hierarchy. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The accounting guidance establishes a three Level 1 Level 2 1 not Level 3 no Guaranteed investment certificates (“GIC”) are classified within Level 2 1, 2 3 Fair Value Measurements as of September 30, 2022 Quoted Prices in Active Markets using Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Assets GIC $ — $ 60 $ — $ 60 Total assets $ — $ 60 $ — $ 60 Fair Value Measurements as of December 31, 2021 Quoted Prices in Active Markets using Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Assets GIC $ — $ 64 $ — $ 64 Total assets $ — $ 64 $ — $ 64

Note 5 - Accounts Receivable

Note 5 - Accounts Receivable	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Trade and Financing Receivables [Text Block]	5. The Company’s products may A financing receivable is a contractual right to receive money, on demand or on fixed or determinable dates, that is recognized as an asset on the Company's unaudited condensed consolidated balance sheets. The Company's financing receivables, consisting of sales-type leases, totaled $45,497 and $53,887 as of September 30, 2022 December 31, 2021 The Company performed an assessment of the allowance for doubtful accounts as of September 30, 2022 December 31, 2021 September 30, 2022 December 31, 2021 A summary of the Company’s accounts receivables is presented below: September 30, December 31, 2022 2021 Gross accounts receivable $ 77,231 $ 86,625 Unearned income (3,930 ) (4,033 ) Allowance for doubtful accounts (13,102 ) (11,997 ) $ 60,199 $ 70,595 Reported as: Current trade receivables $ 40,876 $ 46,918 Current unearned interest income (2,575 ) (2,678 ) Long-term trade receivables 23,253 27,710 Long-term unearned interest income (1,355 ) (1,355 ) $ 60,199 $ 70,595 Current subscription agreements are reported as part of accounts receivable. The following are the contractual commitments, net of allowance for doubtful accounts, to be received by the Company over the next 5 September 30, Total 2022 2023 2024 2025 2026 Current financing receivables, net of allowance of $ 6,293 $ 22,500 $ 22,500 $ — $ — $ — $ — Long-term financing receivables, net of allowance of $ 779 22,997 — 17,499 5,463 35 — $ 45,497 $ 22,500 $ 17,499 $ 5,463 $ 35 $ — Accounts receivable do not not may The allowance for doubtful accounts consisted of the following activity: Balance at January 1, 2021 $ 18,490 Write-offs (6,230 ) Recovery (263 ) Balance at December 31, 2021 11,997 Write-offs (259 ) Provision 1,004 Balance at March 31, 2022 12,742 Write-offs (1,159 ) Provision 2,517 Balance at June 30, 2022 14,100 Write-offs (3,389 ) Provision 2,391 Balance at September 30, 2022 $ 13,102

Note 6 - Select Balance Sheet a

Note 6 - Select Balance Sheet and Statement of Operations Information	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Balance Sheet and Income Statement Disclosures [Text Block]	6. Inventory Inventory consists of the following: September 30, December 31, 2022 2021 Raw materials $ 2,275 $ 2,368 Work-in-progress 1,268 1,649 Finished goods 20,698 16,526 Total inventory $ 24,241 $ 20,543 Additions to inventory are primarily comprised of newly produced units and applicators, refurbishment cost from demonstration units and used equipment which were reacquired during the period from upgraded sale s. The Company expens in cost of goods sold in the three nine September 30, 2022, three nine September 30, 2021, The Company provides for excess and obsolete inventories when conditions indicate that the inventory cost is not September 30, 2022 December 31, 2021 Property and Equipment, Net Property and equipment, net consist of the following: Useful Lives September 30, December 31, (in years) 2022 2021 Lab equipment tooling and molds 4 10 $ 8,056 $ 8,194 Office furniture and equipment 6 10 1,729 1,743 Leasehold improvements up to 10 1,772 1,839 Computers and software 3 2,037 1,939 Vehicles 5 7 37 37 Clinical Training Units 5 214 114 Total property and equipment 13,845 13,866 Less: Accumulated depreciation (11,665 ) (11,197 ) Total property and equipment, net $ 2,180 $ 2,669 Depreciation expense amounted to $206 and $431 for the three September 30, 2022 2021 nine September 30, 2022 2021, Other Current Assets September 30, December 31, 2022 2021 Government remittances (1) $ 1,079 $ 1,322 Consideration receivable from sale of subsidiaries 853 1,405 Deferred financing costs 419 223 Sundry assets and miscellaneous 1,000 808 Total other current assets $ 3,351 $ 3,758 ( 1 Accrued Expenses and Other Current Liabilities September 30, December 31, 2022 2021 Payroll and related expense $ 1,764 $ 1,770 Accrued expenses 6,390 6,584 Commission accrual 3,206 4,529 Sales and consumption taxes 5,975 6,629 Total accrued expenses and other current liabilities $ 17,335 $ 19,512 Warranty Accrual The following table provides the details of the change in the Company’s warranty accrual: September 30, December 31, 2022 2021 Balance as of the beginning of the period $ 1,753 $ 1,639 Warranties issued during the period 509 1,231 Warranty costs incurred during the period (689 ) (1,117 ) Balance at the end of the period $ 1,573 $ 1,753 Current 1,147 1,245 Long-term 426 508 Total $ 1,573 $ 1,753 Finance Expenses Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Interest expense $ 1,153 $ 940 $ 2,979 $ 3,008 Accretion on long-term debt and amortization of fees 66 60 197 1,038 Total finance expenses $ 1,219 $ 1,000 $ 3,176 $ 4,046

Note 7 - Intangible Assets

Note 7 - Intangible Assets	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	7. Intangible assets net of accumulated amortization and goodwill were as follows: At September 30, 2022 Gross Amount Accumulated Amortization Net Amount Customer relationships $ 1,400 $ (405 ) $ 995 Brand 2,500 (1,000 ) 1,500 Technology 16,900 (8,209 ) 8,691 Supplier agreement 3,000 (1,391 ) 1,609 Total intangible assets $ 23,800 $ (11,005 ) $ 12,795 At December 31, 2021 Gross Amount Accumulated Amortization Net Amount Customer relationships $ 1,400 $ (336 ) $ 1,064 Brand 2,500 (803 ) 1,697 Technology 16,900 (6,103 ) 10,797 Supplier agreement 3,000 (1,165 ) 1,835 Total intangible assets $ 23,800 $ (8,407 ) $ 15,393 For the three September 30, 2022 2021 $874, nine September 30, 2022 2021 Estimated amortization expense for the next five Years ending December 31, 2022 $ 875 2023 3,473 2024 3,473 2025 3,004 2026 657 Thereafter 1,313 Total $ 12,795

Note 8 - Commitments and Contin

Note 8 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	8. Operating Leases The Company has various operating lease agreements, which expire on various dates. The Company recognizes rent expense on a straight-line basis over the non-cancellable lease period and records the difference between cash rent payments and the recognition of rent expense as a deferred rent liability. When leases contain escalation clauses, rent abatements and/or concessions, such as rent holidays and landlord or tenant incentives or allowances, the Company applies them in the determination of straight-line rent expense over the lease period. Aggregate future minimum lease payments, and service and purchase commitments with manufacturers as of September 30, 2022 Years ending December 31, Office Lease Purchase and Service Commitments Total 2022 $ 863 $ 17,785 $ 18,648 2023 1,840 - 1,840 2024 1,372 - 1,372 2025 1,135 - 1,135 2026 1,017 - 1,017 Thereafter 1,170 - 1,170 Total $ 7,397 $ 17,785 $ 25,182 The total rent expense for all operating leases for the three September 30, 2022 2021 nine September 30, 2022 2021 Commitments As of September 30, 2022 September 30, 2022 270 On March 25, 2021, four seven November 1, 2022. Legal Proceedings Purported Shareholder Class Actions In 2018 2019, four No. 18CIV02609, No. 19CIV08173 11, 12 2 15 1933 No. 5:18 03712 No. 5:18 03883 11 15 1933 September 1, 2017 October 13, 2017 not September 9, 2021. In the State Actions, the Plaintiffs filed a consolidated amended complaint on January 17, 2020 March 30, 2020, September 1, 2020 September 22, 2020. November 23, 2020, April 20, 2022, April 28, 2022, June 7, 2022, June 27, 2022, July 7, 2022. July 27, 2022, October 25, 2022, no On July 11, 2019, No. 5:19 03997 14 1934 2018 August 21, 2019, June 21, 2021,

Note 9 - Main Street Term Loan

Note 9 - Main Street Term Loan	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Debt Disclosure [Text Block]	9. On December 8, 2020, 13 3 December 9, 2020, five 30 December 8, 2023 December 8, 2024, fifteen December 8, 2025. may As of September 30, 2022 December 31, 2021 The scheduled payments on the outstanding borrowings as of September 30, 2022 Years ending December 31, 2022 $ 781 2023 10,948 2024 9,314 2025 39,580 Total $ 60,623

Note 10 - Madryn Long-term Debt

Note 10 - Madryn Long-term Debt and Convertible Notes	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Debt Disclosure [Text Block]	9. On December 8, 2020, 13 3 December 9, 2020, five 30 December 8, 2023 December 8, 2024, fifteen December 8, 2025. may As of September 30, 2022 December 31, 2021 The scheduled payments on the outstanding borrowings as of September 30, 2022 Years ending December 31, 2022 $ 781 2023 10,948 2024 9,314 2025 39,580 Total $ 60,623
Madryn Long Term Debt and Convertible Notes [Member]
Notes to Financial Statements
Debt Disclosure [Text Block]	10. On October 11, 2016, four September 30, 2020, 1 2 24th September 30, 2022, December 9, 2020 On December 9, 2020, 9 December 8, 2020, December 9, 2020 The Notes will accrue interest at a rate of 8.0% per annum from the date of original issuance of the Notes to the third December 31, 2020. December 9, 2025, December 9, 2020 ( December 9, 2020 ( first not 9 11 three September 30, 2022 2021 nine September 30, 2022 2021 815 10 15 not 815, two September 30, 2022 December 31, 2021 September 30, 2022 December 31, 2021 The scheduled payments on the outstanding borrowings as of September 30, 2022 Years ending December 31, 2022 $ 546 2023 2,131 2024 1,628 2025 28,217 Total $ 32,522 For the three nine September 30, 2022 not

Note 11 - Credit Facility

Note 11 - Credit Facility	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Credit Facility Disclosure [Text Block]	11. CREDIT FACILITY On August 29, 2018, March 20, 2020, December 9, 2020 August 26, 2021 ( August 29, 2018, March 20, 2020, December 9, 2020 August 26, 2021 ( March 20, 2020, December 9, 2020 August 26, 2021, The CNB Loan Agreement contains various covenants that limit the Company’s ability to engage in specified types of transactions. Subject to limited exceptions, these covenants limit the Company’s ability, without CNB’s consent, to, among other things, sell, lease, transfer, exclusively license or dispose of the Company’s assets, incur, create or permit to exist additional indebtedness, or liens, to make dividends and certain other restricted payments, and to make certain changes to its management and/or ownership structure. The Company is required to maintain $3,000 in cash in a deposit account maintained with CNB at all times during the term of the CNB Loan Agreement. In addition, the CNB Loan Agreement contains certain covenants that require the Company to achieve certain minimum account balances, or a minimum debt service coverage ratio and a maximum total liability to tangible net worth ratio. If the Company fails to comply with these covenants, it will result in a default and require the Company to repay all outstanding principal amounts and any accrued interest. In connection with the CNB Loan Agreement, a loan fee of $1,000 was paid in equal installments on January 25, February 25 March 25, 2021. On August 26, 2021, 30 December 10, 2021, As of September 30, 2022 December 31, 2021 9 In connection with the Amended CNB Loan Agreement, the Company, Venus USA and Venus Canada issued a promissory note dated August 26, 2021, July 24, 2023 August 26, 2021 (

Note 12 - Government Assistance

Note 12 - Government Assistance Programs	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Government Assistance Programs [Text Block]	12. Venus Concept Inc. and Venus USA, received funding in the total amount of $4,048 in connection with two 7 1953, Venus Concept Inc. entered into a U.S. Small Business Administration Note dated as of April 21, 2020 April 29, 2020 ( 1% two Venus USA entered into a U.S. Small Business Administration Note dated as of April 15, 2020 April 20, 2020 ( The Venus Concept PPP Loan contained certain covenants which, among other things, restrict the Company’s use of the proceeds of the PPP Loan to the payment of payroll costs, interest on mortgage obligations, rent obligations and utility expenses, require compliance with all other loans or other agreements with any creditor of the Company, to the extent that a default under any loan or other agreement would materially affect the Company’s ability to repay its PPP Loan and limit the Company’s ability to make certain changes to its ownership structure. In 2021, three March 31, 2022, April 2022. September 30, 2022 ad $nil December 31, 2021

Note 13 - Common Stock Reserved

Note 13 - Common Stock Reserved for Issuance	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Common Stock Reserved For Issuance [Text Block]	13. The Company is required to reserve and keep available out of its authorized but unissued shares of common stock a number of shares sufficient to affect the exercise of all options granted and available for grant under the incentive plans, warrants to purchase common stock and preferred shares which are convertible to common stock. September 30, 2022 December 31, 2021 Outstanding common stock warrants 15,928,867 15,928,867 Outstanding stock options and RSUs 7,483,514 5,977,179 Preferred shares 3,790,755 3,790,755 Shares reserved for conversion of future preferred share issuance 1,209,245 1,209,245 Shares reserved for future option grants and RSUs 1,624,130 589,064 Shares reserved for Lincoln Park 21,814,471 5,222,867 Shares reserved for Madryn Noteholders 8,213,880 8,213,880 Total common stock reserved for issuance 60,064,862 40,931,857

Note 14 - Stockholders Equity

Note 14 - Stockholders Equity	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	14. Common Stock The Company’s common stock confers upon its holders the following rights: ● The right to participate and vote in the Company’s stockholder meetings, whether annual or special. Each share will entitle its holder, when attending and participating in the voting in person or via proxy, to one ● The right to a share in the distribution of dividends, whether in cash or in the form of bonus shares, the distribution of assets or any other distribution pro rata to the par value of the shares held by them; and ● The right to a share in the distribution of the Company’s excess assets upon liquidation pro rata to the par value of the shares held by them. Equity Purchase Agreement with Lincoln Park On June 16, 2020, may may no no 5635 no may From commencement to expiry on July 1, 2022, 2022, September 30, 2022 July 1, 2022, 2022 2022 On July 12, 2022, "2022 July 1, 2022. 2022 may 2022 “2022 2022 2022 may not 2022 “2022 2022 2022 no 2022 2022 five 2022 2022 2022 2022 may not 2022 2022 2022 September 30, 2022, 2022 8 July 12, 2022. The 2021 In December 2021, “2021 2021 December 15, 2021. 2021 2021 2021 2021 10 March 28, 2022. Preferred Stock issued in December 2021 As noted above, in December 2021, December 14, 2021. • Voting Rights. no • Liquidation. not • Conversion 1:1, not • Dividends. • Redemption not • Maturity. Upon issuance, the effective conversion price of the Preferred Stock of $1.25 per share was lower than the market price of the Company’s common stock on the date of issuance of the Preferred Stock of $1.29 per share; as a result, the Company recorded the beneficial conversion feature of $152 in accumulated paid in capital (“APIC”). Because the Preferred Stock is perpetual, it is carried at the amount recorded at inception. Upon conversion of the Preferred Stock, the beneficial conversion feature will be accounted for as a deemed dividend. The Company evaluated the Preferred Stock for liability or equity classification in accordance with the provisions of ASC 480, not not not not 480 Since the Preferred Stock was sold as a unit with the common stock, the proceeds received were allocated to each instrument on a relative fair value basis. Total net proceeds of $16,740 reduced by $152 of the beneficial conversion feature were allocated as follows: $4,514 to the Preferred Stock and $12,074 to shares of common stock. The Preferred Stock and common stock issued in the 2021 2010 In November 2010, “2010 2010 seven ten November 2017 2010 not September 30, 2022 2010 December 31, 2021 2019 Incentive Award Plan The 2019 “2019 2017 September 12, 2017 September 14, 2017. 2017 October 4, 2019. Under the 2019 2019 September 30, 2022 2019 December 31, 2021 2019 first 2020 2029 four The Company recognized stock-based compensation for its employees and non-employees in the accompanying unaudited condensed consolidated statements of operations as follows: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Cost of sales $ 31 $ 8 $ 52 $ 23 Sales and marketing 139 211 448 652 General and administrative 317 289 868 850 Research and development 64 28 184 77 Total stock-based compensation $ 551 $ 536 $ 1,552 $ 1,602 Stock Options The fair value of each option is estimated at the date of grant using the Black-Scholes option pricing formula with the following assumptions : Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Expected term (in years) 6.00 6.00 6.00 6.00 Risk-free interest rate 2.96 % 0.98 % 2.56-2.96 % 0.98-1.09 % Expected volatility 42.93 % 43.66 % 42.59 % 44.69 % Expected dividend rate 0 % 0 % 0 % 0 % Expected Term Volatility not Risk-Free Interest Rate zero Dividend Rate not Fair Value of Common Stock The following table summarizes stock option activity under the Company’s stock option plans: Number of Shares Weighted- Average Exercise Price per Share, $ Weighted- Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding – January 1, 2022 5,977,179 $ 3.72 7.20 $ 136 Options granted 2,383,250 1.27 Options exercised (16,464 ) 1.59 Options forfeited/cancelled (1,249,201 ) 4.20 — — Outstanding - September 30, 2022 7,094,764 $ 2.82 7.55 $ — Exercisable – September 30, 2022 3,146,660 $ 3.99 5.75 $ — Expected to vest – after September 30, 2022 3,948,104 $ 1.89 8.99 $ — The following tables summarize information about stock options outstanding and exercisable at September 30, 2022 Options Outstanding Options Exercisable Exercise Price Range Number Weighted average remaining contractual term (years) Weighted average Exercise Price Options exercisable Weighted average remaining contractual term (years) Weighted average Exercise Price $0.67 - $3.64 6,188,582 7.90 $ 2.13 2,295,735 5.99 $ 2.65 $4.26 - $7.95 860,692 5.22 6.62 806,450 5.10 6.64 $12.45 - $26.10 26,543 6.00 18.09 25,528 6.00 18.11 $27.00 - $33.00 10,768 2.47 27.32 10,768 2.47 27.32 $36.00 - $94.65 8,179 5.04 45.65 8,179 5.04 45.65 7,094,764 7.55 $ 2.82 3,146,660 5.75 $ 3.99 The aggregate intrinsic value of options is calculated as the difference between the exercise price of the stock options and the fair value of the Company’s common stock for those options that had exercise prices lower than the fair value of the Company’s common stock. The total intrinsic value of options exercised were $nil three September 30, 2022 2021, $nil nine September 30, 2022 2021, The weighted-average grant date fair value of options granted was $0.58 three September 30, 2022 2021, nine September 30, 2022 2021, three September 30, 2022 2021 nine September 30, 2022 2021 Restricted Stock Units The following table summarizes information about RSUs outstanding at September 30, 2022 Number of Shares Weighted- Average Grant Date Fair Value per Share, $ Outstanding – January 1, 2022 — $ — RSUs granted 396,250 1.30 RSUs forfeited/cancelled (7,500 ) 1.38 Outstanding - September 30, 2022 388,750 $ 1.30

Note 15 - Income Taxes

Note 15 - Income Taxes	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Income Tax Disclosure [Text Block]	15. The Company generated a loss and recognize d $162 of tax benefit for the three September 30, 2022 , and $616 of tax expense for the three September 30, 2021 , respectively. The Company generated a loss and recognized $92 of tax expense for the nine September 30, 2022 , and $609 of tax expense for the nine September 30, 2021 , respectively. A reconciliation of income tax (benefit) expense is as follows: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Loss before income taxes $ (14,658 ) $ (8,222 ) $ (33,552 ) $ (17,422 ) Theoretical tax (expense) benefit at the statutory rate ( 21.0 (3,078 ) (1,727 ) (7,046 ) (3,659 ) Differences in jurisdictional tax rates (654 ) (313 ) (1,247 ) (716 ) Valuation allowance 3,142 2,388 7,327 4,687 Non-deductible expenses 427 268 1,058 207 Other 1 — — 90 Total income tax (benefit) provision (162 ) 616 92 609 Net loss $ (14,496 ) $ (8,838 ) $ (33,644 ) $ (18,031 ) Income tax expense or benefit is recognized based on the actual loss incurred during the three nine September 30, 2022 2021

Note 16 - Segment and Geographi

Note 16 - Segment and Geographic Information	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	16. Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company's CODM is its Chief Executive Officer. The Company has determined it operates in a single operating segment and has one reportable segment, as the CODM reviews financial information presented on a consolidated basis accompanied by disaggregated information about revenues by geography and type for purposes of making operating decisions, allocating resources, and evaluating financial performance. The Company does not Revenue by geographic location, which is based on the product shipped to location, is summarized as follows: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 United States $ 11,774 $ 12,259 $ 38,319 $ 35,345 International 9,765 12,304 36,892 37,643 Total revenue $ 21,539 $ 24,563 $ 75,211 $ 72,988 As of September 30, 2022 were located in the United States and $1,626 December 31, 2021 Revenue by type is a key indicator for providing management with an understanding of the Company’s financial performance, which is organized into four 1. 2. 3. 4. The following table presents revenue by type: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Lease revenue $ 7,193 $ 12,634 $ 29,490 $ 33,958 System revenue 10,416 8,022 33,838 26,526 Product revenue 3,125 2,961 9,702 9,330 Service revenue 805 946 2,181 3,174 Total revenue $ 21,539 $ 24,563 $ 75,211 $ 72,988

Note 17 - Related Party Transac

Note 17 - Related Party Transactions	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	17. All amounts were recorded at the exchange amount, which is the amount established and agreed to by the related parties. Distribution agreements On January 1, 2018, three September 30, 2022 2021 t of $192 and $66, respectively, under this distribution agreement. These sales are included in products and services revenue. For the nine September 30, 2022 2021 , TBC purchased products in the amount of $928 and $194, resp In 2020, January 1, 2021, will continue to distribute the Company’s products in Singapore. A senior officer of the Company is a 45.0% shareholder of Aexel Biomed. During the three September 30, 2022 2021 , Aexel Biomed purchased products in the amount of $57 and $51, respectively, under the distribution agreement. During the nine September 30, 2022 2021 , Aexel Biomed purchased products in the amount of $376 and $165, respectively, under the distribution agreement. These sales are included in products and services revenue.

Note 18 - Subsequent Events

Note 18 - Subsequent Events	9 Months Ended
	Sep. 30, 2022
Notes to Financial Statements
Subsequent Events [Text Block]	18. Separation of Domenic Serafino as Chief Executive Officer On October 3, 2022, October 2, 2022. not 8 October 3, 2022 Appointment of Chief Executive Officer On October 3, 2022, October 2, 2022. seventy-five first 8 October 3, 2022 Appointment of President and Chief Business Officer On October 11, 2022, October 17, 2022. first Sale of Stock to LPC Between October 3, 2022, November 8, 2022, 14 2022

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying unaudited condensed consolidated financial statements of Venus Concept Inc. have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and with the instructions to Form 10 10 X. not 10 December 31, 2021 March 28, 2022. nine September 30, 2022 not may December 31, 2022. 8 10 In the Form 10 March 31, 2021, May 17, 2021, 10 June 30, 2021, August 17, 2021, 10 September 30, 2021, November 12, 2021 10 December 31, 2021, March 28, 2022, 16 Reclassification Adjustment Three Months Ended Year Ended March 31, 2021 June 30, 2021 September 30, 2021 December 31, 2021 December 31, 2021 United States $ (362 ) $ (615 ) $ (703 ) $ (440 ) $ (2,120 ) International 362 615 703 440 2,120 Total revenue $ — $ — $ — $ — $ — The preparation of these unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ materially from those estimates. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company as of September 30, 2022 not Amounts reported in thousands within this report are computed based on the amounts in dollars. As a result, the sum of the components reported in thousands may not may not
Accounting Policies [Policy Text Block]	Accounting Policies The accounting policies the Company follows are set forth in the Company’s audited consolidated financial statements for fiscal year 2021 8 10 no
JOBS Act Accounting Election [Policy Text Block]	JOBS Act Accounting Election The Company is an emerging growth company, within the meaning of the 1933 no may not
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Adopted Accounting Standards In November 2021, No. 2021 10, 832 December 31, 2021. 12 In May 2021, 2021 04, 260 470 50 718 815 40 1 2 December 15, 2021, not In December 2019, 2019 12 740 first 2022, not Recently Issued Accounting Standards Not In October 2021, No. 2021 08, 805 606, December 15, 2022, In August 2020, No. 2020 06 2020 06” 470 20 815 40 2020 06 2020 06 January 1, 2024, No. 2020 06 In April 2020, 842 840: 19 19. 19 In March 2020, 2020 04 848 2021, March 12, 2020 December 31, 2022. may no December 31, 2022. January 2021, may 848. not In February 2020, 2020 02 326 842 326 842. 326, 326 January 1, 2023,

Note 2 - Summary of Significa_2

Note 2 - Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]	Reclassification Adjustment Three Months Ended Year Ended March 31, 2021 June 30, 2021 September 30, 2021 December 31, 2021 December 31, 2021 United States $ (362 ) $ (615 ) $ (703 ) $ (440 ) $ (2,120 ) International 362 615 703 440 2,120 Total revenue $ — $ — $ — $ — $ —

Note 3 - Net Loss Per Share (Ta

Note 3 - Net Loss Per Share (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Numerator: Net loss $ (14,496 ) $ (8,838 ) $ (33,644 ) $ (18,031 ) Net loss allocated to stockholders of the Company $ (14,605 ) $ (9,798 ) $ (33,783 ) $ (18,680 ) Denominator: Weighted-average shares of common stock outstanding used in computing net loss per share, basic 65,255 54,145 64,462 53,994 Weighted-average shares of common stock outstanding used in computing net loss per share, diluted 65,255 54,145 64,462 53,994 Net loss per share: Basic $ (0.22 ) $ (0.18 ) $ (0.52 ) $ (0.35 ) Diluted $ (0.22 ) $ (0.18 ) $ (0.52 ) $ (0.35 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	September 30, 2022 September 30, 2021 Options to purchase common stock and restricted stock units ("RSUs") 7,483,514 5,695,900 Preferred stock 3,790,755 - Shares reserved for convertible notes 8,213,880 8,213,880 Warrants for common stock 15,928,867 15,928,867 Total potential dilutive shares 35,417,016 29,838,647

Note 4 - Fair Value Measureme_2

Note 4 - Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Fair Value, by Balance Sheet Grouping [Table Text Block]	Fair Value Measurements as of September 30, 2022 Quoted Prices in Active Markets using Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Assets GIC $ — $ 60 $ — $ 60 Total assets $ — $ 60 $ — $ 60 Fair Value Measurements as of December 31, 2021 Quoted Prices in Active Markets using Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Assets GIC $ — $ 64 $ — $ 64 Total assets $ — $ 64 $ — $ 64

Note 5 - Accounts Receivable (T

Note 5 - Accounts Receivable (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	September 30, December 31, 2022 2021 Gross accounts receivable $ 77,231 $ 86,625 Unearned income (3,930 ) (4,033 ) Allowance for doubtful accounts (13,102 ) (11,997 ) $ 60,199 $ 70,595 Reported as: Current trade receivables $ 40,876 $ 46,918 Current unearned interest income (2,575 ) (2,678 ) Long-term trade receivables 23,253 27,710 Long-term unearned interest income (1,355 ) (1,355 ) $ 60,199 $ 70,595
Contractual Commitments, Net of Allowance For Doubtful Accounts To Be Received Maturity [Table Text Block]	September 30, Total 2022 2023 2024 2025 2026 Current financing receivables, net of allowance of $ 6,293 $ 22,500 $ 22,500 $ — $ — $ — $ — Long-term financing receivables, net of allowance of $ 779 22,997 — 17,499 5,463 35 — $ 45,497 $ 22,500 $ 17,499 $ 5,463 $ 35 $ —
Accounts Receivable, Allowance for Credit Loss [Table Text Block]	Balance at January 1, 2021 $ 18,490 Write-offs (6,230 ) Recovery (263 ) Balance at December 31, 2021 11,997 Write-offs (259 ) Provision 1,004 Balance at March 31, 2022 12,742 Write-offs (1,159 ) Provision 2,517 Balance at June 30, 2022 14,100 Write-offs (3,389 ) Provision 2,391 Balance at September 30, 2022 $ 13,102

Note 6 - Select Balance Sheet_2

Note 6 - Select Balance Sheet and Statement of Operations Information (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Inventory, Current [Table Text Block]	September 30, December 31, 2022 2021 Raw materials $ 2,275 $ 2,368 Work-in-progress 1,268 1,649 Finished goods 20,698 16,526 Total inventory $ 24,241 $ 20,543
Property, Plant and Equipment [Table Text Block]	Useful Lives September 30, December 31, (in years) 2022 2021 Lab equipment tooling and molds 4 10 $ 8,056 $ 8,194 Office furniture and equipment 6 10 1,729 1,743 Leasehold improvements up to 10 1,772 1,839 Computers and software 3 2,037 1,939 Vehicles 5 7 37 37 Clinical Training Units 5 214 114 Total property and equipment 13,845 13,866 Less: Accumulated depreciation (11,665 ) (11,197 ) Total property and equipment, net $ 2,180 $ 2,669
Schedule of Other Current Assets [Table Text Block]	September 30, December 31, 2022 2021 Government remittances (1) $ 1,079 $ 1,322 Consideration receivable from sale of subsidiaries 853 1,405 Deferred financing costs 419 223 Sundry assets and miscellaneous 1,000 808 Total other current assets $ 3,351 $ 3,758
Schedule of Accrued Expenses and Other Current Liabilities [Table Text Block]	September 30, December 31, 2022 2021 Payroll and related expense $ 1,764 $ 1,770 Accrued expenses 6,390 6,584 Commission accrual 3,206 4,529 Sales and consumption taxes 5,975 6,629 Total accrued expenses and other current liabilities $ 17,335 $ 19,512
Schedule of Product Warranty Liability [Table Text Block]	September 30, December 31, 2022 2021 Balance as of the beginning of the period $ 1,753 $ 1,639 Warranties issued during the period 509 1,231 Warranty costs incurred during the period (689 ) (1,117 ) Balance at the end of the period $ 1,573 $ 1,753 Current 1,147 1,245 Long-term 426 508 Total $ 1,573 $ 1,753
Schedule of Finance Expenses [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Interest expense $ 1,153 $ 940 $ 2,979 $ 3,008 Accretion on long-term debt and amortization of fees 66 60 197 1,038 Total finance expenses $ 1,219 $ 1,000 $ 3,176 $ 4,046

Note 7 - Intangible Assets (Tab

Note 7 - Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Finite-Lived Intangible Assets [Table Text Block]	At September 30, 2022 Gross Amount Accumulated Amortization Net Amount Customer relationships $ 1,400 $ (405 ) $ 995 Brand 2,500 (1,000 ) 1,500 Technology 16,900 (8,209 ) 8,691 Supplier agreement 3,000 (1,391 ) 1,609 Total intangible assets $ 23,800 $ (11,005 ) $ 12,795 At December 31, 2021 Gross Amount Accumulated Amortization Net Amount Customer relationships $ 1,400 $ (336 ) $ 1,064 Brand 2,500 (803 ) 1,697 Technology 16,900 (6,103 ) 10,797 Supplier agreement 3,000 (1,165 ) 1,835 Total intangible assets $ 23,800 $ (8,407 ) $ 15,393
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Years ending December 31, 2022 $ 875 2023 3,473 2024 3,473 2025 3,004 2026 657 Thereafter 1,313 Total $ 12,795

Note 8 - Commitments and Cont_2

Note 8 - Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Contractual Obligation, Fiscal Year Maturity [Table Text Block]	Years ending December 31, Office Lease Purchase and Service Commitments Total 2022 $ 863 $ 17,785 $ 18,648 2023 1,840 - 1,840 2024 1,372 - 1,372 2025 1,135 - 1,135 2026 1,017 - 1,017 Thereafter 1,170 - 1,170 Total $ 7,397 $ 17,785 $ 25,182

Note 9 - Main Street Term Loan

Note 9 - Main Street Term Loan (Tables)	9 Months Ended
	Sep. 30, 2022
MSLP Note [Member]
Notes Tables
Schedule of Maturities of Long-Term Debt [Table Text Block]	Years ending December 31, 2022 $ 781 2023 10,948 2024 9,314 2025 39,580 Total $ 60,623

Note 10 - Madryn Long-term De_2

Note 10 - Madryn Long-term Debt and Convertible Notes (Tables)	9 Months Ended
	Sep. 30, 2022
Secured Subordinated Convertible Notes [Member]
Notes Tables
Schedule of Maturities of Long-Term Debt [Table Text Block]	Years ending December 31, 2022 $ 546 2023 2,131 2024 1,628 2025 28,217 Total $ 32,522

Note 13 - Common Stock Reserv_2

Note 13 - Common Stock Reserved for Issuance (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Common Stock Reserved for Issuance [Table Text Block]	September 30, 2022 December 31, 2021 Outstanding common stock warrants 15,928,867 15,928,867 Outstanding stock options and RSUs 7,483,514 5,977,179 Preferred shares 3,790,755 3,790,755 Shares reserved for conversion of future preferred share issuance 1,209,245 1,209,245 Shares reserved for future option grants and RSUs 1,624,130 589,064 Shares reserved for Lincoln Park 21,814,471 5,222,867 Shares reserved for Madryn Noteholders 8,213,880 8,213,880 Total common stock reserved for issuance 60,064,862 40,931,857

Note 14 - Stockholders Equity (

Note 14 - Stockholders Equity (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Cost of sales $ 31 $ 8 $ 52 $ 23 Sales and marketing 139 211 448 652 General and administrative 317 289 868 850 Research and development 64 28 184 77 Total stock-based compensation $ 551 $ 536 $ 1,552 $ 1,602
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Expected term (in years) 6.00 6.00 6.00 6.00 Risk-free interest rate 2.96 % 0.98 % 2.56-2.96 % 0.98-1.09 % Expected volatility 42.93 % 43.66 % 42.59 % 44.69 % Expected dividend rate 0 % 0 % 0 % 0 %
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Number of Shares Weighted- Average Exercise Price per Share, $ Weighted- Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding – January 1, 2022 5,977,179 $ 3.72 7.20 $ 136 Options granted 2,383,250 1.27 Options exercised (16,464 ) 1.59 Options forfeited/cancelled (1,249,201 ) 4.20 — — Outstanding - September 30, 2022 7,094,764 $ 2.82 7.55 $ — Exercisable – September 30, 2022 3,146,660 $ 3.99 5.75 $ — Expected to vest – after September 30, 2022 3,948,104 $ 1.89 8.99 $ —
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]	Options Outstanding Options Exercisable Exercise Price Range Number Weighted average remaining contractual term (years) Weighted average Exercise Price Options exercisable Weighted average remaining contractual term (years) Weighted average Exercise Price $0.67 - $3.64 6,188,582 7.90 $ 2.13 2,295,735 5.99 $ 2.65 $4.26 - $7.95 860,692 5.22 6.62 806,450 5.10 6.64 $12.45 - $26.10 26,543 6.00 18.09 25,528 6.00 18.11 $27.00 - $33.00 10,768 2.47 27.32 10,768 2.47 27.32 $36.00 - $94.65 8,179 5.04 45.65 8,179 5.04 45.65 7,094,764 7.55 $ 2.82 3,146,660 5.75 $ 3.99
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]	Number of Shares Weighted- Average Grant Date Fair Value per Share, $ Outstanding – January 1, 2022 — $ — RSUs granted 396,250 1.30 RSUs forfeited/cancelled (7,500 ) 1.38 Outstanding - September 30, 2022 388,750 $ 1.30

Note 15 - Income Taxes (Tables)

Note 15 - Income Taxes (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Loss before income taxes $ (14,658 ) $ (8,222 ) $ (33,552 ) $ (17,422 ) Theoretical tax (expense) benefit at the statutory rate ( 21.0 (3,078 ) (1,727 ) (7,046 ) (3,659 ) Differences in jurisdictional tax rates (654 ) (313 ) (1,247 ) (716 ) Valuation allowance 3,142 2,388 7,327 4,687 Non-deductible expenses 427 268 1,058 207 Other 1 — — 90 Total income tax (benefit) provision (162 ) 616 92 609 Net loss $ (14,496 ) $ (8,838 ) $ (33,644 ) $ (18,031 )

Note 16 - Segment and Geograp_2

Note 16 - Segment and Geographic Information (Tables)	9 Months Ended
	Sep. 30, 2022
Notes Tables
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 United States $ 11,774 $ 12,259 $ 38,319 $ 35,345 International 9,765 12,304 36,892 37,643 Total revenue $ 21,539 $ 24,563 $ 75,211 $ 72,988
Revenue from External Customers by Products and Services [Table Text Block]	Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Lease revenue $ 7,193 $ 12,634 $ 29,490 $ 33,958 System revenue 10,416 8,022 33,838 26,526 Product revenue 3,125 2,961 9,702 9,330 Service revenue 805 946 2,181 3,174 Total revenue $ 21,539 $ 24,563 $ 75,211 $ 72,988

Note 1 - Nature of Operations (

Note 1 - Nature of Operations (Details Textual) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended	3 Months Ended		9 Months Ended		24 Months Ended
	Dec. 15, 2021	Feb. 28, 2021	Sep. 30, 2022	Jun. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2022	Dec. 31, 2021	Dec. 09, 2020	Jun. 16, 2020
Retained Earnings (Accumulated Deficit), Total			$ (214,188)		$ (214,188)			$ (180,405)
Proceeds from Issuance of Common Stock					$ 415	$ 0
Common Stock, Par or Stated Value Per Share (in dollars per share)			$ 0.0001		$ 0.0001			$ 0.0001	$ 0.0001
Proceeds from Issuance of Private Placement	$ 16,740
Proceeds from Warrant Exercises					$ 0	903
Proceeds from Divestiture of Businesses, Net of Cash Divested, Total					0	$ (40)
Venus Spain [Member] | Employee Severance and Retention [Member]
Restructuring Charges, Total			$ 126		126
Venus Colombia, Venus Canada, Venus France, and Venus Argentina [Member] | Disposal Group, Not Discontinued Operations [Member]
Proceeds from Divestiture of Businesses, Net of Cash Divested, Total			0		0
Venus Colombia, Venus France, and Venus Argentina [Member] | Disposal Group, Not Discontinued Operations [Member]
Restructuring and Related Cost, Expected Cost, Total			$ 0		0
December 2020 Public Offering Warrants [Member]
Class of Warrant or Right, Exercised During Period (in shares)		361,200
Class of Warrant or Right, Exercised During Period, Exercise Price (in dollars per share)		$ 2.50
Proceeds from Warrant Exercises		$ 903
Series A Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.0001
Proceeds from Issuance of Private Placement	$ 4,514
Common Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares)			1,185,529	400,000
Proceeds from Issuance of Private Placement	12,074
Equity Purchase Agreement [Member] | Lincoln Park [Member]
Equity Purchase Agreement, Maximum Offering Amount										$ 31,000
Agreement Term (Year)										2 years
Proceeds from Issuance of Common Stock					$ 272
Stock Issued During Period, Shares, New Issues (in shares)					400,000		3,437,521
Common Stock, Par or Stated Value Per Share (in dollars per share)										$ 0.0001
The 2021 Private Placement [Member]
Proceeds from Issuance of Private Placement	$ 16,999
The 2021 Private Placement [Member] | Series A Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares)	3,790,755
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.0001
The 2021 Private Placement [Member] | Common Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares)	9,808,418
Common Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.0001

Note 2 - Summary of Significa_3

Note 2 - Summary of Significant Accounting Policies - Reclassification Adjustment (Details) - USD ($) $ in Thousands	3 Months Ended					9 Months Ended		12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Revenues	$ 21,539		$ 24,563			$ 75,211	$ 72,988
Revision of Prior Period, Error Correction, Adjustment [Member]
Revenues		$ 0	0	$ 0	$ 0			$ 0
UNITED STATES | Revision of Prior Period, Error Correction, Adjustment [Member]
Revenues		(440)	(703)	(615)	(362)			(2,120)
Non-US [Member] | Revision of Prior Period, Error Correction, Adjustment [Member]
Revenues		$ 440	$ 703	$ 615	$ 362			$ 2,120

Note 3 - Net Loss Per Share - C

Note 3 - Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Net loss	$ (14,496)			$ (8,838)			$ (33,644)	$ (18,031)
Loss attributable to stockholders of the Company	$ (14,605)	$ (10,559)	$ (8,619)	$ (9,798)	$ 377	$ (9,259)	$ (33,783)	$ (18,680)
Weighted-average shares of common stock outstanding used in computing net loss per share, basic (in shares)	65,255			54,145			64,462	53,994
Weighted-average shares of common stock outstanding used in computing net loss per share, diluted (in shares)	65,255			54,145			64,462	53,994
Basic (in dollars per share)	$ (0.22)			$ (0.18)			$ (0.52)	$ (0.35)
Diluted (in dollars per share)	$ (0.22)			$ (0.18)			$ (0.52)	$ (0.35)

Note 3 - Net Loss Per Share - A

Note 3 - Net Loss Per Share - Antidilutive Securities (Details) - shares	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Total potential dilutive shares (in shares)	35,417,016	29,838,647
Share-Based Payment Arrangement, Option [Member]
Total potential dilutive shares (in shares)	7,483,514	5,695,900
Preferred Stock [Member]
Total potential dilutive shares (in shares)	3,790,755	0
Shares Reserved for Convertible Notes [Member]
Total potential dilutive shares (in shares)	8,213,880	8,213,880
Warrant [Member]
Total potential dilutive shares (in shares)	15,928,867	15,928,867

Note 4 - Fair Value Measureme_3

Note 4 - Fair Value Measurements - Fair Value Measurements (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
GIC	$ 60	$ 64
Guaranteed Investment Certificates [Member]
GIC	60	64
Fair Value, Inputs, Level 1 [Member]
GIC	0	0
Fair Value, Inputs, Level 1 [Member] | Guaranteed Investment Certificates [Member]
GIC	0	0
Fair Value, Inputs, Level 2 [Member]
GIC	60	64
Fair Value, Inputs, Level 2 [Member] | Guaranteed Investment Certificates [Member]
GIC	60	64
Fair Value, Inputs, Level 3 [Member]
GIC	0	0
Fair Value, Inputs, Level 3 [Member] | Guaranteed Investment Certificates [Member]
GIC	$ 0	$ 0

Note 5 - Accounts Receivable (D

Note 5 - Accounts Receivable (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Lessor, Sales-type Lease, Term of Contract (Month)	36 months
Sales-type and Direct Financing Leases, Lease Receivable	$ 45,497			$ 53,887
Accounts Receivable, Allowance for Credit Loss, Ending Balance	$ 13,102	$ 14,100	$ 12,742	$ 11,997	$ 18,490

Note 5 - Accounts Receivable -

Note 5 - Accounts Receivable - Summary of Accounts Receivable (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Gross accounts receivable	$ 77,231			$ 86,625
Unearned income	(3,930)			(4,033)
Allowance for doubtful accounts	(13,102)	$ (14,100)	$ (12,742)	(11,997)	$ (18,490)
Accounts Receivable, after Allowance for Credit Loss, Total	60,199			70,595
Current trade receivables	40,876			46,918
Current unearned interest income	(2,575)			(2,678)
Long-term trade receivables	23,253			27,710
Long-term unearned interest income	$ (1,355)			$ (1,355)

Note 5 - Accounts Receivable _2

Note 5 - Accounts Receivable - Schedule of Contractual Commitments, Net of Allowance for Doubtful Accounts (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Total, current financing receivables, net	$ 45,497
2022, current financing receivables, net	22,500
2023, current financing receivables, net	17,499
2024, current financing receivables, net	5,463
2025, current financing receivables, net	35
2026, current financing receivables, net	0
Current Financing Receivables, Net Of Allowance [Member]
Total, current financing receivables, net	22,500
2022, current financing receivables, net	22,500
2023, current financing receivables, net	0
2024, current financing receivables, net	0
2025, current financing receivables, net	0
2026, current financing receivables, net	0
Noncurrent Financing Receivables, Net Of Allowance [Member]
Total, current financing receivables, net	22,997
2022, current financing receivables, net	0
2023, current financing receivables, net	17,499
2024, current financing receivables, net	5,463
2025, current financing receivables, net	35
2026, current financing receivables, net	$ 0

Note 5 - Accounts Receivable _3

Note 5 - Accounts Receivable - Schedule of Contractual Commitments, Net of Allowance for Doubtful Accounts (Details) (Parentheticals) $ in Thousands	Sep. 30, 2022 USD ($)
Current Financing Receivables, Net Of Allowance [Member]
Allowance, current financing receivables, net	$ 6,293
Noncurrent Financing Receivables, Net Of Allowance [Member]
Allowance, long-term financing receivables, net	$ 779

Note 5 - Accounts Receivable _4

Note 5 - Accounts Receivable - Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Balance	$ 14,100	$ 12,742	$ 11,997	$ 11,997	$ 18,490	$ 18,490
Write-offs	(3,389)	(1,159)	(259)			(6,230)
(Recovery) Provision	2,391	2,517	1,004	5,912	$ (628)	(263)
Balance	$ 13,102	$ 14,100	$ 12,742	$ 13,102		$ 11,997

Note 6 - Select Balance Sheet_3

Note 6 - Select Balance Sheet and Statement of Operations Information (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Cost, Direct Material	$ 7,696	$ 6,584	$ 23,437	$ 19,150
Inventory Valuation Reserves	3,194		3,194		$ 2,213
Depreciation, Total	$ 206	$ 431	$ 695	$ 1,159

Note 6 - Select Balance Sheet_4

Note 6 - Select Balance Sheet and Statement of Operations Information - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Raw materials	$ 2,275	$ 2,368
Work-in-progress	1,268	1,649
Finished goods	20,698	16,526
Total inventory	$ 24,241	$ 20,543

Note 6 - Select Balance Sheet_5

Note 6 - Select Balance Sheet and Statement of Operations Information - Property and Equipment, Net (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Lab equipment tooling and molds	$ 8,056	$ 8,194
Office furniture and equipment	1,729	1,743
Leasehold improvements	1,772	1,839
Computers and software	2,037	1,939
Vehicles	37	37
Clinical Training Units	214	114
Total property and equipment	13,845	13,866
Less: Accumulated depreciation	(11,665)	(11,197)
Total property and equipment, net	$ 2,180	$ 2,669
Tools, Dies and Molds [Member] | Minimum [Member]
Property and equipment, Useful lives (Year)	4 years
Tools, Dies and Molds [Member] | Maximum [Member]
Property and equipment, Useful lives (Year)	10 years
Office Equipment [Member] | Minimum [Member]
Property and equipment, Useful lives (Year)	6 years
Office Equipment [Member] | Maximum [Member]
Property and equipment, Useful lives (Year)	10 years
Computer Equipment [Member]
Property and equipment, Useful lives (Year)	3 years
Vehicles [Member] | Minimum [Member]
Property and equipment, Useful lives (Year)	5 years
Vehicles [Member] | Maximum [Member]
Property and equipment, Useful lives (Year)	7 years
Clinical Training Units [Member]
Property and equipment, Useful lives (Year)	5 years

Note 6 - Select Balance Sheet_6

Note 6 - Select Balance Sheet and Statement of Operations Information - Other Current Assets (Details) - USD ($) $ in Thousands		Sep. 30, 2022	Dec. 31, 2021
Government remittances (1)	[1]	$ 1,079	$ 1,322
Consideration receivable from sale of subsidiaries		853	1,405
Deferred financing costs		419	223
Sundry assets and miscellaneous		1,000	808
Total other current assets		$ 3,351	$ 3,758
[1]Government remittances are receivables from the local tax authorities for refund of sales taxes and income taxes.

Note 6 - Select Balance Sheet_7

Note 6 - Select Balance Sheet and Statement of Operations Information - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Payroll and related expense	$ 1,764	$ 1,770
Accrued expenses	6,390	6,584
Commission accrual	3,206	4,529
Sales and consumption taxes	5,975	6,629
Total accrued expenses and other current liabilities	$ 17,335	$ 19,512

Note 6 - Select Balance Sheet_8

Note 6 - Select Balance Sheet and Statement of Operations Information - Warranty Accrual (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Balance as of the beginning of the period	$ 1,753	$ 1,639
Warranties issued during the period	509	1,231
Warranty costs incurred during the period	(689)	(1,117)
Balance at the end of the period	1,573	1,753
Current	1,147	1,245
Long-term	426	508
Total	$ 1,573	$ 1,753

Note 6 - Select Balance Sheet_9

Note 6 - Select Balance Sheet and Statement of Operations Information - Finance Expenses (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Interest expense	$ 1,153	$ 940	$ 2,979	$ 3,008
Accretion on long-term debt and amortization of fees	66	60	197	1,038
Total finance expenses	$ 1,219	$ 1,000	$ 3,176	$ 4,046

Note 7 - Intangible Assets (Det

Note 7 - Intangible Assets (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Amortization of Intangible Assets	$ 875	$ 874	$ 2,598	$ 2,597

Note 7 - Intangible Assets - Sc

Note 7 - Intangible Assets - Schedule of Intangible Assets Net of Accumulated Amortization and Goodwill (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Gross Amount	$ 23,800	$ 23,800
Accumulated amortization	(11,005)	(8,407)
Net Amount	12,795	15,393
Customer Relationships [Member]
Gross Amount	1,400	1,400
Accumulated amortization	(405)	(336)
Net Amount	995	1,064
Brand [Member]
Gross Amount	2,500	2,500
Accumulated amortization	(1,000)	(803)
Net Amount	1,500	1,697
Technology [Member]
Gross Amount	16,900	16,900
Accumulated amortization	(8,209)	(6,103)
Net Amount	8,691	10,797
Supplier Agreement [Member]
Gross Amount	3,000	3,000
Accumulated amortization	(1,391)	(1,165)
Net Amount	$ 1,609	$ 1,835

Note 7 - Intangible Assets - Es

Note 7 - Intangible Assets - Estimated Amortization (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
2022, estimated amortization expense	$ 875
2023, estimated amortization expense	3,473
2024, estimated amortization expense	3,473
2025, estimated amortization expense	3,004
2026, estimated amortization expense	657
Thereafter	1,313
Total, estimated amortization expense	$ 12,795	$ 15,393

Note 8 - Commitments and Cont_3

Note 8 - Commitments and Contingencies (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating Lease, Expense	$ 637	$ 528	$ 1,950	$ 1,623
Purchase Obligation, Total	17,785		17,785
Contract Manufacturers [Member]
Purchase Obligation, Total	16,506		16,506
Open Purchase Order [Member]
Purchase Obligation, Total	$ 5,119		$ 5,119
Percentage Of Open Purchase Order			25%

Note 8 - Commitments and Cont_4

Note 8 - Commitments and Contingencies - Aggregate Future Minimum Lease Payments (Details) $ in Thousands	Sep. 30, 2022 USD ($)
2022, office lease	$ 863
2022, purchase and service commitments	17,785
2022, total	18,648
2023, office lease	1,840
2023, total	1,840
2024, office lease	1,372
2024, total	1,372
2025, office lease	1,135
2025, total	1,135
2026, office lease	1,017
2026, total	1,017
Thereafter, office lease	1,170
Thereafter, total	1,170
Total, office lease	7,397
Purchase and service commitments	17,785
Total, total	$ 25,182

Note 9 - Main Street Term Loa_2

Note 9 - Main Street Term Loan (Details Textual) - MSLP Note [Member] - USD ($) $ in Millions	Dec. 08, 2024	Dec. 08, 2023	Dec. 08, 2020
Debt Instrument, Face Amount			$ 50
Debt Instrument, Term (Year)			5 years
Forecast [Member]
Debt Instrument, Percentage of Outstanding Principal to be Paid with Accrued Unpaid Interest	15%	15%
London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument, Basis Spread on Variable Rate			3%

Note 9 - Main Street Term Loa_3

Note 9 - Main Street Term Loan - Schedule Payments on Outstanding Borrowings (Details) - MSLP Note [Member] $ in Thousands	Sep. 30, 2022 USD ($)
2022, scheduled payments	$ 781
2023, scheduled payments	10,948
2024, scheduled payments	9,314
2025, scheduled payments	39,580
Total, scheduled payments	$ 60,623

Note 10 - Madryn Long-term De_3

Note 10 - Madryn Long-term Debt and Convertible Notes (Details Textual) - USD ($)		3 Months Ended		9 Months Ended
	Dec. 09, 2020	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Sep. 30, 2020	Oct. 11, 2016
Common Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.0001	$ 0.0001		$ 0.0001		$ 0.0001
Madryn Credit Agreement [Member]
Repayments of Debt	$ 42,500,000
Madryn Credit Agreement [Member] | Madryn Noteholders [Member]
Debt Instrument, Face Amount								$ 70,000,000
Madryn Credit Agreement [Member] | Madryn Noteholders [Member] | Term A-1, A-2 and B Tranches of Debt [Member]
Long-term Debt, Gross							$ 60,000,000
Secured Subordinated Convertible Notes [Member] | Madryn Noteholders [Member]
Debt Instrument, Face Amount	$ 26,695,000
Debt Instrument, Default, Increase in Interest Rate	4%
Debt Instrument, Termination, Minimum Principal Outstanding	$ 10,000
Debt Instrument, Convertible, Conversion Price (in dollars per share)	$ 3.25
Interest Expense, Total		$ 546,000	$ 546,000	$ 1,086,000	$ 1,613,000
Secured Subordinated Convertible Notes [Member] | Madryn Noteholders [Member] | Original Issuance Of Notes To Third Anniversary Date [Member]
Debt Instrument, Interest Rate, Stated Percentage	8%
Secured Subordinated Convertible Notes [Member] | Madryn Noteholders [Member] | After the Third Anniversary [Member]
Debt Instrument, Interest Rate, Stated Percentage	6%

Note 10 - Madryn Long-term De_4

Note 10 - Madryn Long-term Debt and Convertible Notes - Scheduled Payments (Details) - Secured Subordinated Convertible Notes [Member] $ in Thousands	Sep. 30, 2022 USD ($)
2022, scheduled payments	$ 546
2023, scheduled payments	2,131
2024, scheduled payments	1,628
2025, scheduled payments	28,217
Total, scheduled payments	$ 32,522

Note 11 - Credit Facility (Deta

Note 11 - Credit Facility (Details Textual) - City National Bank of Florida [Member] - USD ($) $ in Millions	Aug. 26, 2021	Dec. 09, 2020
CNB Note [Member]
Debt Instrument, Face Amount	$ 5
Revolving Credit Facility [Member]
Line of Credit Facility, Minimum Deposit Required	1.5	$ 3
Loan Processing Fee		1
Line of Credit Facility, Maximum Borrowing Capacity	$ 5	$ 10
Debt Instrument, LIBOR Floor	0.50%
Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument, Basis Spread on Variable Rate	3.25%

Note 12 - Government Assistan_2

Note 12 - Government Assistance Programs (Details Textual) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended	9 Months Ended		12 Months Ended
	Apr. 29, 2020	Apr. 30, 2022	Mar. 31, 2022	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Apr. 20, 2020
Repayments of Secured Debt				$ 543	$ 0
Repayments of Secured Debt				543	$ 0
SBA CARES Act Paycheck Protection Program [Member]
Proceeds from Loans	$ 4,048
Repayments of Secured Debt		$ 136	$ 407
Repayments of Secured Debt		$ 136	$ 407
Long-Term Debt, Total				$ 0		$ 543
SBA CARES Act Paycheck Protection Program [Member] | Venus Concept Inc [Member]
Debt Instrument, Face Amount	$ 1,665
Debt Instrument, Decrease, Forgiveness						1,086
SBA CARES Act Paycheck Protection Program [Member] | Venus USA [Member]
Debt Instrument, Face Amount							$ 2,383
Debt Instrument, Decrease, Forgiveness						$ 1,689

Note 13 - Common Stock Reserv_3

Note 13 - Common Stock Reserved for Issuance - Common Stock Reserved for Issuance (Details) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Outstanding stock options and RSUs (in dollars per share)	$ 7,483,514	$ 5,977,179
Shares reserved for conversion of future preferred share issuance (in shares)	1,209,245	1,209,245
Shares reserved for future option grants and RSUs (in shares)	1,624,130	589,064
Total common stock reserved for issuance (in shares)	60,064,862	40,931,857
Lincoln Park [Member]
Total common stock reserved for issuance (in shares)	21,814,471	5,222,867
Madryn Noteholders [Member]
Total common stock reserved for issuance (in shares)	8,213,880	8,213,880
Common Stock [Member]
Outstanding common stock warrants (in shares)	15,928,867	15,928,867
Preferred Stock [Member]
Preferred shares (in shares)	3,790,755	3,790,755

Note 14 - Stockholders Equity_2

Note 14 - Stockholders Equity (Details Textual) $ / shares in Units, $ in Thousands			1 Months Ended		3 Months Ended				9 Months Ended		12 Months Ended	24 Months Ended
	Jul. 12, 2022 USD ($) $ / shares shares	Dec. 15, 2021 USD ($) $ / shares shares	Nov. 30, 2017	Nov. 30, 2010	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) $ / shares	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) $ / shares	Dec. 31, 2021 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) $ / shares shares	Dec. 09, 2020 $ / shares	Jun. 16, 2020 USD ($) $ / shares shares	Oct. 04, 2019 shares
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares					$ 0.0001	$ 0.0001			$ 0.0001		$ 0.0001		$ 0.0001
Proceeds from Issuance of Common Stock									$ 415	$ 0
Stock Issued During Period, Value, New Issues						$ 562	$ 48
Proceeds from Issuance of Private Placement		$ 16,740
Adjustments to Additional Paid in Capital, Convertible Preferred Stock with Beneficial Conversion Feature		152
Common Stock, Capital Shares Reserved for Future Issuance (in shares) | shares					60,064,862	60,064,862			60,064,862		40,931,857
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments									$ 0
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value						$ 0		$ 19	$ 0	$ 285
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares						$ 0.58		$ 2.09	$ 1.27	$ 2.33
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value						$ 317		$ 380	$ 1,197	$ 1,180
The 2010 Share Option Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)			10 years	7 years
Common Stock, Capital Shares Reserved for Future Issuance (in shares) | shares					400,812	400,812			400,812		212,650
The 2019 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares) | shares															450,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares) | shares					1,223,318	1,223,318			1,223,318		376,414
Share-based Compensation Arrangement by Share-based Payment Award, Increase in Authorized Shares, Percentage of Outstanding Stock Maximum									4%
Common Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares						1,185,529	400,000
Stock Issued During Period, Value, New Issues						$ 0	$ 0
Proceeds from Issuance of Private Placement		$ 12,074
Series A Preferred Stock [Member]
Shares Issued, Price Per Share (in dollars per share) | $ / shares											$ 1.29
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares		$ 0.0001
Proceeds from Issuance of Private Placement		$ 4,514
Preferred Stock, Shares Outstanding, Ending Balance (in shares) | shares											3,790,755
Preferred Stock, Convertible, Conversion Ratio											1
Preferred Stock, Maximum Conversion Cap Percentage											9.99%
Dividends Payable											$ 0
Preferred Stock, Convertible, Conversion Price (in dollars per share) | $ / shares											$ 1.25
Adjustments to Additional Paid in Capital, Convertible Preferred Stock with Beneficial Conversion Feature											$ 152
Equity Purchase Agreement [Member] | Lincoln Park [Member]
Equity Purchase Agreement, Maximum Offering Amount														$ 31,000
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares														$ 0.0001
Equity Purchase Agreement, Maximum Shares Issuable (in shares) | shares														7,763,411
Equity Agreement, Maximum Percentage of Stock Outstanding														19.99%
Equity Agreement, Minimum Average Purchase Price (in dollars per share) | $ / shares														$ 3.9755
Maximum Percentage of Outstanding Stock, Beneficial Ownership														9.99%
Stock Issued During Period, Shares, New Issues (in shares) | shares									400,000			3,437,521
Shares Issued, Price Per Share (in dollars per share) | $ / shares							$ 2.70					$ 2.70
Stock Issued During Period, Shares, Commitment Fee (in shares) | shares												209,566,000
Stock Issued During Period, Value, Commitment Fee												$ 620
Deferred Offering Costs					$ 0	$ 0	$ 123		$ 0			$ 123
Proceeds from Issuance of Common Stock									$ 272
LPC Purchase Agreement 2022 [Member] | Lincoln Park [Member]
Equity Purchase Agreement, Maximum Offering Amount	$ 11,000
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares	$ 0.0001
Equity Purchase Agreement, Maximum Shares Issuable (in shares) | shares	12,873,368
Equity Agreement, Maximum Percentage of Stock Outstanding	19.99%
Maximum Percentage of Outstanding Stock, Beneficial Ownership	9.99%
Stock Issued During Period, Shares, New Issues (in shares) | shares					500,000
Shares Issued, Price Per Share (in dollars per share) | $ / shares					$ 0.50	$ 0.50			$ 0.50
Stock Issued During Period, Shares, Commitment Fee (in shares) | shares	685,529
Stock Issued During Period, Value, Commitment Fee	$ 330
Stock Issued During Period, Value, New Issues					$ 251
The 2021 Private Placement [Member]
Proceeds from Issuance of Private Placement		16,999
Payments of Stock Issuance Costs		$ 259
The 2021 Private Placement [Member] | Common Stock [Member]
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares		$ 0.0001
Stock Issued During Period, Shares, New Issues (in shares) | shares		9,808,418
The 2021 Private Placement [Member] | Common Stock [Member]
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares											$ 0.0001
Stock Issued During Period, Shares, New Issues (in shares) | shares											9,808,418
The 2021 Private Placement [Member] | Convertible Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares											3,790,755
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares											$ 0.0001
Preferred Stock, Convertible, Shares Issuable (in shares) | shares											3,790,755
The 2021 Private Placement [Member] | Series A Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares		3,790,755
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares		$ 0.0001

Note 14 - Stockholders Equity -

Note 14 - Stockholders Equity - Stock-based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Total stock-based compensation	$ 551	$ 536	$ 1,552	$ 1,602
Cost of Sales [Member]
Total stock-based compensation	31	8	52	23
Selling and Marketing Expense [Member]
Total stock-based compensation	139	211	448	652
General and Administrative Expense [Member]
Total stock-based compensation	317	289	868	850
Research and Development Expense [Member]
Total stock-based compensation	$ 64	$ 28	$ 184	$ 77

Note 14 - Stockholders Equity_3

Note 14 - Stockholders Equity - Stock Options Assumptions (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Expected term (in years) (Year)	6 years	6 years	6 years	6 years
Risk-free interest rate	2.96%	0.98%
Expected volatility	42.93%	43.66%	42.59%	44.69%
Expected dividend rate	0%	0%	0%	0%
Minimum [Member]
Risk-free interest rate			2.56%	0.98%
Maximum [Member]
Risk-free interest rate			2.96%	1.09%

Note 14 - Stockholders Equity_4

Note 14 - Stockholders Equity - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Outstanding, number of shares (in shares)	5,977,179
Outstanding, weighted average exercise price (in dollars per share)	$ 3.72
Outstanding, weighted average remaining contractual term (Year)	7 years 6 months 18 days	7 years 2 months 12 days
Outstanding, aggregate intrinsic value	$ 0	$ 136
Options granted, number of shares (in shares)	2,383,250
Options granted, weighted average exercise price (in dollars per share)	$ 1.27
Options exercised, number of shares (in shares)	(16,464)
Options exercised, weighted average exercise price (in dollars per share)	$ 1.59
Options forfeited/cancelled, number of shares (in shares)	(1,249,201)
Options forfeited/cancelled, weighted average exercise price (in dollars per share)	$ 4.20
Options forfeited/cancelled, aggregate intrinsic value (in dollars per share)	$ 0
Outstanding, number of shares (in shares)	7,094,764	5,977,179
Outstanding, weighted average exercise price (in dollars per share)	$ 2.82	$ 3.72
Exercisable, number of shares (in shares)	3,146,660
Exercisable, weighted average exercise price (in dollars per share)	$ 3.99
Exercisable, weighted average remaining contractual term (Year)	5 years 9 months
Exercisable, aggregate intrinsic value	$ 0
Expected to vest, number of shares (in shares)	3,948,104
Expected to vest, weighted average exercise price (in dollars per share)	$ 1.89
Expected to vest, weighted average remaining contractual term (Year)	8 years 11 months 26 days
Expected to vest, aggregate intrinsic value	$ 0

Note 14 - Stockholders Equity_5

Note 14 - Stockholders Equity - Stock Options Outstanding and Exercisable (Details)	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Options outstanding, number (in shares) | shares	7,094,764
Options outstanding, weighted average remaining contractual term (Year)	7 years 6 months 18 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 2.82
Options exercisable (in shares) | shares	3,146,660
Options exercisable, weighted average remaining contractual term (Year)	5 years 9 months
Options exercisable, weighted average exercise price (in dollars per share)	$ 3.99
Range One [Member]
Exercise price range, lower limit (in dollars per share)	0.67
Exercise price range, upper limit (in dollars per share)	$ 3.64
Options outstanding, number (in shares) | shares	6,188,582
Options outstanding, weighted average remaining contractual term (Year)	7 years 10 months 24 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 2.13
Options exercisable (in shares) | shares	2,295,735
Options exercisable, weighted average remaining contractual term (Year)	5 years 11 months 26 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 2.65
Range Two [Member]
Exercise price range, lower limit (in dollars per share)	4.26
Exercise price range, upper limit (in dollars per share)	$ 7.95
Options outstanding, number (in shares) | shares	860,692
Options outstanding, weighted average remaining contractual term (Year)	5 years 2 months 19 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 6.62
Options exercisable (in shares) | shares	806,450
Options exercisable, weighted average remaining contractual term (Year)	5 years 1 month 6 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 6.64
Range Three [Member]
Exercise price range, lower limit (in dollars per share)	12.45
Exercise price range, upper limit (in dollars per share)	$ 26.10
Options outstanding, number (in shares) | shares	26,543
Options outstanding, weighted average remaining contractual term (Year)	6 years
Options outstanding, weighted average exercise price (in dollars per share)	$ 18.09
Options exercisable (in shares) | shares	25,528
Options exercisable, weighted average remaining contractual term (Year)	6 years
Options exercisable, weighted average exercise price (in dollars per share)	$ 18.11
Range Four [Member]
Exercise price range, lower limit (in dollars per share)	27
Exercise price range, upper limit (in dollars per share)	$ 33
Options outstanding, number (in shares) | shares	10,768
Options outstanding, weighted average remaining contractual term (Year)	2 years 5 months 19 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 27.32
Options exercisable (in shares) | shares	10,768
Options exercisable, weighted average remaining contractual term (Year)	2 years 5 months 19 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 27.32
Range Five [Member]
Exercise price range, lower limit (in dollars per share)	36
Exercise price range, upper limit (in dollars per share)	$ 94.65
Options outstanding, number (in shares) | shares	8,179
Options outstanding, weighted average remaining contractual term (Year)	5 years 14 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 45.65
Options exercisable (in shares) | shares	8,179
Options exercisable, weighted average remaining contractual term (Year)	5 years 14 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 45.65

Note 14 - Stockholders Equity_6

Note 14 - Stockholders Equity - Restricted Stock Units Activity (Details) - Restricted Stock Units (RSUs) [Member]	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Outstanding (in shares) | shares	0
Outstanding (in dollars per share) | $ / shares	$ 0
RSUs granted (in shares) | shares	396,250
RSUs granted (in dollars per share) | $ / shares	$ 1.30
RSUs forfeited/cancelled (in shares) | shares	(7,500)
RSUs forfeited/cancelled (in dollars per share) | $ / shares	$ 1.38
Outstanding (in shares) | shares	388,750
Outstanding (in dollars per share) | $ / shares	$ 1.30

Note 15 - Income Taxes (Details

Note 15 - Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Tax Expense (Benefit), Total	$ (162)	$ 616	$ 92	$ 609

Note 15 - Income Taxes - Reconc

Note 15 - Income Taxes - Reconciliation of Income Tax Expense (Benefit) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Loss before income taxes	$ (14,658)	$ (8,222)	$ (33,552)	$ (17,422)
Theoretical tax (expense) benefit at the statutory rate (21.0% in 2022 and 2021)	(3,078)	(1,727)	(7,046)	(3,659)
Differences in jurisdictional tax rates	(654)	(313)	(1,247)	(716)
Valuation allowance	3,142	2,388	7,327	4,687
Non-deductible expenses	427	268	1,058	207
Other	1	0	0	90
Total income tax (benefit) provision	(162)	616	92	609
Net loss	$ (14,496)	$ (8,838)	$ (33,644)	$ (18,031)

Note 15 - Income Taxes - Reco_2

Note 15 - Income Taxes - Reconciliation of Income Tax Expense (Benefit) (Details) (Parentheticals)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statutory Rate	21%	21%	21%	21%

Note 16 - Segment and Geograp_3

Note 16 - Segment and Geographic Information (Details Textual) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)
Number of Reportable Segments	1
Leases [Member]
Sales with Typical Lease Terms (Month)	36 months
System [Member]
Sales with Payment Terms (Month)	12 months
UNITED STATES
Long-Lived Assets	$ 13,358	$ 16,090
Non-US [Member]
Long-Lived Assets	$ 1,626	$ 1,972

Note 16 - Segment and Geograp_4

Note 16 - Segment and Geographic Information - Schedule of Revenue by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Total revenue	$ 21,539	$ 24,563	$ 75,211	$ 72,988
UNITED STATES
Total revenue	11,774	12,259	38,319	35,345
Non-US [Member]
Total revenue	$ 9,765	$ 12,304	$ 36,892	$ 37,643

Note 16 - Segment and Geograp_5

Note 16 - Segment and Geographic Information - Schedule of Revenue by Type (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Total revenue	$ 21,539	$ 24,563	$ 75,211	$ 72,988
Leases [Member]
Total revenue	7,193	12,634	29,490	33,958
System [Member]
Total revenue	10,416	8,022	33,838	26,526
Product [Member]
Total revenue	3,125	2,961	9,702	9,330
Service [Member]
Total revenue	$ 805	$ 946	$ 2,181	$ 3,174

Note 17 - Related Party Trans_2

Note 17 - Related Party Transactions (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2020	Jan. 01, 2021	Jan. 01, 2018
Venus Concept Singapore Pte. Ltd (Venus Singapore) [Member]
Disposal Group, Including Discontinued Operation, Percentage of Ownership					55%
Senior Officer [Member] | Technicalbiomed Co., Ltd. (TBC) [Member]
Equity Method Investment, Ownership Percentage						45%	30%
Technicalbiomed Co., Ltd. (TBC) [Member]
Revenue from Related Parties	$ 192	$ 66	$ 928	$ 194
Venus Concept Singapore Pte. Ltd (Venus Singapore) [Member]
Revenue from Related Parties	$ 57	$ 51	$ 376	$ 165

Note 18 - Subsequent Events (De

Note 18 - Subsequent Events (Details Textual) - USD ($) $ / shares in Units, $ in Thousands			1 Months Ended	3 Months Ended	9 Months Ended
	Oct. 17, 2022	Oct. 02, 2022	Nov. 08, 2022	Sep. 30, 2022	Sep. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)					2,383,250
LPC Purchase Agreement 2022 [Member] | Lincoln Park [Member]
Stock Issued During Period, Shares, New Issues (in shares)				500,000
Shares Issued, Price Per Share (in dollars per share)				$ 0.50	$ 0.50
Subsequent Event [Member] | LPC Purchase Agreement 2022 [Member] | Lincoln Park [Member]
Stock Issued During Period, Shares, New Issues (in shares)			2,000,000
Shares Issued, Price Per Share (in dollars per share)			$ 0.29
Subsequent Event [Member] | Chief Executive Officer [Member]
Annual Base Salary		$ 525
Annual Incentive Bonus, Percentage of Base Salary		75%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)		3,300,000
Subsequent Event [Member] | Chief Executive Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		25%
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)		1 year
Subsequent Event [Member] | Chief Executive Officer [Member] | Share-Based Payment Arrangement, Tranche Two [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		75%
Subsequent Event [Member] | Chief Executive Officer [Member] | Vesting Per Quarter [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage		6.25%
Subsequent Event [Member] | President and Chief Business Officer [Member]
Annual Base Salary	$ 370
Annual Incentive Bonus, Percentage of Base Salary	60%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)	1,100,000
Subsequent Event [Member] | President and Chief Business Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage	25%
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)	1 year
Subsequent Event [Member] | President and Chief Business Officer [Member] | Share-Based Payment Arrangement, Tranche Two [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage	75%
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)	3 years